"Melanoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
| Descriptor ID |
D008545
|
| MeSH Number(s) |
C04.557.465.625.650.510 C04.557.580.625.650.510 C04.557.665.510
|
| Concept/Terms |
Melanoma- Melanoma
- Melanomas
- Malignant Melanoma
- Malignant Melanomas
- Melanoma, Malignant
- Melanomas, Malignant
|
Below are MeSH descriptors whose meaning is more general than "Melanoma".
Below are MeSH descriptors whose meaning is more specific than "Melanoma".
This graph shows the total number of publications written about "Melanoma" by people in this website by year, and whether "Melanoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 3 | 2 | 5 |
| 1995 | 6 | 1 | 7 |
| 1996 | 4 | 1 | 5 |
| 1997 | 1 | 0 | 1 |
| 1998 | 3 | 0 | 3 |
| 1999 | 9 | 1 | 10 |
| 2000 | 5 | 0 | 5 |
| 2001 | 5 | 1 | 6 |
| 2002 | 5 | 2 | 7 |
| 2003 | 4 | 0 | 4 |
| 2004 | 9 | 1 | 10 |
| 2005 | 6 | 4 | 10 |
| 2006 | 12 | 0 | 12 |
| 2007 | 5 | 2 | 7 |
| 2008 | 10 | 2 | 12 |
| 2009 | 11 | 1 | 12 |
| 2010 | 9 | 3 | 12 |
| 2011 | 11 | 2 | 13 |
| 2012 | 19 | 2 | 21 |
| 2013 | 17 | 2 | 19 |
| 2014 | 13 | 2 | 15 |
| 2015 | 17 | 2 | 19 |
| 2016 | 15 | 0 | 15 |
| 2017 | 18 | 1 | 19 |
| 2018 | 13 | 0 | 13 |
| 2019 | 18 | 1 | 19 |
| 2020 | 11 | 2 | 13 |
| 2021 | 13 | 2 | 15 |
| 2022 | 10 | 0 | 10 |
| 2023 | 13 | 0 | 13 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Melanoma" by people in Profiles.
-
Photoacoustic imaging for cutaneous melanoma assessment: a comprehensive review. J Biomed Opt. 2024 Jan; 29(Suppl 1):S11518.
-
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients. Eur J Cancer. 2024 Mar; 199:113530.
-
Melanoma and microbiota: Current understanding and future directions. Cancer Cell. 2024 01 08; 42(1):16-34.
-
Chemoimmunotherapy for Untreated Lung Cancer Brain Metastases: Systemic Before Local Therapy? J Clin Oncol. 2024 Mar 01; 42(7):858-859.
-
Engineered IL-7 synergizes with IL-12 immunotherapy to prevent T cell exhaustion and promote memory without exacerbating toxicity. Sci Adv. 2023 12; 9(48):eadh9879.
-
Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017. Cancer. 2024 03 01; 130(5):750-769.
-
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases. Oncoimmunology. 2023; 12(1):2261264.
-
Machine learning identification of patient clusters for cutaneous melanoma. Ital J Dermatol Venerol. 2023 Oct; 158(5):388-394.
-
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With ATM Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. JCO Precis Oncol. 2023 Sep; 7:e2300279.
-
Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO Precis Oncol. 2023 Sep; 7:e2300385.